Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?
- PMID: 21854526
- DOI: 10.1111/j.1464-410X.2011.10582.x
Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?
Comment on
-
Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?BJU Int. 2011 Sep;108(5):699. doi: 10.1111/j.1464-410X.2010.10006.x. Epub 2010 Nov 24. BJU Int. 2011. PMID: 21854525 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
